Evidence map›Paper›PMID 37223742›Full record

ReviewmicroLife2023

The mysterious diadenosine tetraphosphate (AP4A).

Victor Zegarra, Christopher-Nils Mais, Johannes Freitag, Gert Bange

Open access · goldAbstract readReview
In one paragraph

Review in microLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 14 citations in OpenAlex.

  1. Loss of the ApJournal of bacteriology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Molecular insights into the promiscuous ApThe Journal of biological chemistry · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Victor ZegarraDepartment of Chemistry and Center for Synthetic Microbiology, Philipps University Marburg, Marburg 35043, Germany.ORCID https://orcid.org/0000-0002-3485-2725
Christopher-Nils MaisDepartment of Chemistry and Center for Synthetic Microbiology, Philipps University Marburg, Marburg 35043, Germany.
Johannes FreitagDepartment of Biology, Philipps University Marburg, Marburg 35043, Germany.
Gert BangeDepartment of Chemistry and Center for Synthetic Microbiology, Philipps University Marburg, Marburg 35043, Germany.ORCID https://orcid.org/0000-0002-7826-0932
Loewe Center for Synthetic Microbiology · DEPhilipps University of Marburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dinucleoside polyphosphates, a class of nucleotides found amongst all the Trees of Life, have been gathering a lot of attention in the past decades due to their putative role as cellular alarmones. In particular, diadenosine tetraphosphate (AP4A) has been widely studied in bacteria facing various environmental challenges and has been proposed to be important for ensuring cellular survivability through harsh conditions. Here, we discuss the current understanding of AP4A synthesis and degradation, protein targets, their molecular structure where possible, and insights into the molecular mechanisms of AP4A action and its physiological consequences. Lastly, we will briefly touch on what is known with regards to AP4A beyond the bacterial kingdom, given its increasing appearance in the eukaryotic world. Altogether, the notion that AP4A is a conserved second messenger in organisms ranging from bacteria to humans and is able to signal and modulate cellular stress regulation seems promising.

Indexed as

alarmonesAP4Adinucleoside polyphosphatesheat shocknucleotide signalingoxidative stress

Identifiers

PMID37223742
PMCPMC10148737
OpenAlexW4366988473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.